Spironolactone therapy is associated with reduced ventricular tachycardia rate in patients with cardiomyopathy.
Dimas
Vassilis
V
Department of Internal Medicine (Cardiology), University of Texas Southwestern Medical Center, Dallas, Texas 75390-8573, USA.
Ayers
Colby
C
Daniels
James
J
Joglar
Jose A
JA
Hill
Joseph A
JA
Naseem
R Haris
RH